Virax Biolabs Ownership

Stocks . USA . 
Stock . Virax Biolabs Group
VRAX Stock  USD 1.22  0.05  3.94%   
Virax Biolabs Group has 6.63 % of its outstanding shares held by insiders and 6.72 % owned by institutional holders.
Some institutional investors establish a significant position in stocks such as Virax Biolabs in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Virax Biolabs, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Virax Biolabs Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Virax Stock Ownership Analysis

The company has Price to Book (P/B) ratio of 0.62. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Virax Biolabs Group recorded a loss per share of 2.61. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 18th of December 2023. Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. Virax Biolabs Group Limited was incorporated in 2021 and is headquartered in London, the United Kingdom. Virax Biolabs is traded on NASDAQ Exchange in the United States. For more information please call James Foster at 44 20 7788 7414 or visit https://viraxbiolabs.com.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
SSentinelOne
GMGeneral Motors

Additional Tools for Virax Stock Analysis

When running Virax Biolabs' price analysis, check to measure Virax Biolabs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virax Biolabs is operating at the current time. Most of Virax Biolabs' value examination focuses on studying past and present price action to predict the probability of Virax Biolabs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virax Biolabs' price. Additionally, you may evaluate how the addition of Virax Biolabs to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY